Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.40
+0.15 (2.07%)
At close: Aug 29, 2025, 4:00 PM
7.26
-0.14 (-1.89%)
After-hours: Aug 29, 2025, 7:22 PM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $495.00 million as of August 29, 2025. Its market cap has decreased by -5.08% in one year.
Market Cap
495.00M
Enterprise Value
822.75M
1-Year Change
-5.08%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $495.00M, a decrease of -30.62%. That is a compound annual growth rate of -7.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 495.00M | -27.88% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |